Long-term outcomes after treatment of in-stent restenosis using the Absorb everolimus-eluting bioresorbable scaffold

Long-term outcomes after treatment of in-stent restenosis using the Absorb everolimus-eluting bioresorbable scaffold

Background Early studies evaluating the performance of bioresorbable scaffold (BRS) Absorb in in-stent restenosis (ISR) lesions indicated promising short-term to mid-term outcomes.Aims To evaluate long-term outcomes (up to 5 years) of patients with ISR treated with the Absorb BRS.Methods We did an o...

Full description

Saved in:
Bibliographic Details
Main Authors: Stefan Toggweiler, Matthias Bossard, Florim Cuculi, Federico Moccetti, Mathias Wolfrum, Richard Kobza, Adrian Attinger-Toller, Mehdi Madanchi, Giacomo Maria Cioffi, Thomas Seiler, Luca Vercelli, Philipp Burkart
Format: Article
Language:English
Published: BMJ Publishing Group 2021-12-01
Series:Open Heart
Online Access:https://openheart.bmj.com/content/8/2/e001776.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://openheart.bmj.com/content/8/2/e001776.full

Similar Items